Physician

John B Kelly, MD

According to 2025 Medicare claims, John Kelly, MD (NPI: 1407855315) practices neurology in the Anchorage, AK market, with the plurality of this provider's patient population coming from Matanuska-Susitna, AK. This provider's primary affiliated billing organization is NORTHERN NEUROLOGY, LLC (NPI: 1306684980; TIN: 991699418) and primary practice location at 99654-7274.

Kelly's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 294 traditional Medicare patients, billed 23,965 HCPCS/CPT codes, and received $417,867 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 433 prescription claims across 134 beneficiaries totaling $53,164 in drug costs, led by Lamotrigine Er (Lamotrigine). 2023 DME data shows 16 claims. Open Payments data shows 29 records totaling $854. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $249,618 to $417,867. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $1,536,496 to $53,164. For DME billing, this smaller-volume category started with an early spike, then settled into a lower baseline, moving from $5,957 to $1,803.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	448	13,960	$249,618
2016	358	14,247	$227,796
2017	211	4,835	$90,558
2018	N/R	N/R	N/R
2019	343	592	$36,303
2020	406	931	$55,433
2021	335	624	$47,526
2022	270	512	$39,025
2023	230	3,804	$77,851
2024	294	23,965	$417,867

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	882	11,277	$1,536,496
2016	805	8,854	$1,172,975
2017	706	4,968	$706,100
2018	53	138	$7,244
2019	272	1,630	$240,828
2020	385	3,474	$604,212
2021	390	2,971	$655,626
2022	388	2,591	$440,617
2023	344	2,054	$412,098
2024	134	433	$53,164

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$122
2016	N/R	N/R	N/R
2017	N/R	26	$1,380
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	20	$1,427
2021	N/R	13	$585
2022	N/R	N/R	N/R
2023	N/R	16	$661
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	115	115	$212
95911	Nerve conduction, 9-10 studies	59	75	$200
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	45	54	$172
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	91	126	$118
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	70	119	$88

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lamotrigine Er	Lamotrigine	16	582	$1,881
Memantine Hcl	Memantine Hcl	30	2,140	$1,336
Entacapone	Entacapone	11	380	$848
Carbidopa-Levodopa	Carbidopa/Levodopa	24	1,010	$772
Levetiracetam	Levetiracetam	22	921	$691

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	29	$854	TG Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John B. Kelly, MD?

Tedicare shows public-source Medicare data for John B. Kelly, MD (NPI 1407855315), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John B. Kelly, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John B. Kelly, MD?

John B. Kelly, MD is linked to NORTHERN NEUROLOGY, LLC (billing NPI 1306684980) in the available physician profile data.

Does John B. Kelly, MD have Open Payments data?

John B. Kelly, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.